Article
Evaluation of γ-Retroviral Vectors That Mediate the Inducible Expression of IL-12 for Clinical Application
9 May 2012
Abstract excerpt
The clinical application of interleukin-12 (IL-12) has been hindered by the toxicity associated with its systemic administration. To potentially overcome this problem, we developed a promoter designed to direct IL-12 expression within the tumor environment using an inducible composite promoter containing binding motifs for the nuclear factor of activated T cells (NFAT) linked to a minimal IL-2 promoter. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
